NCT02000284Active, not recruiting
Mitochondrial Dysfunction in Autism Spectrum Disorder
Defining Subgroups of Mitochondrial Disease and Dysfunction in Autism Spectrum Disorder
Source: ClinicalTrials.gov · Last updated 22 Jan 2026
Brief summary (registry, in English)
Researchers at Arkansas Children's Hospital Research Institute are conducting a study about mitochondrial function in children. The study involves up to 5 visits to Arkansas Children's Hospital with fasting blood draws, behavioral assessments, and/or questionnaires. This study is not currently recruiting, but continues to follow those who were enrolled. There is no cost for visits or study-related exams. For further information, please contact the program manager, Leanna Delhey, at or 501-364-4519
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 297 (actual)
- First submitted
- 21 Nov 2013
- Start date
- Oct 2012
- Primary completion date
- Dec 2026
- Lead sponsor
- University of Arkansas
- Diseases
- Autism
- NCT number
- NCT02000284
What you commit to
- Study type: Observational
- Participants enrolled: 297
- From Oct 2012 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Discussed on a case by case basis
Who the study is looking for
- Autism Spectrum Disorder (As defined by a gold standard measure for ASD diagnosis: the Autism Diagnostic Observation Schedule, Autism Diagnostic Interview, and/or the minimum Arkansas state requirement for autism classification, as defined by a consensus diagnosis of ASD by a medical doctor, speech pathologist, and psychologist.). In an event where sufficient diagnostic information is lacking, and the PI believes that the clients meet all other inclusion criteria and a prospective diagnosis of an ASD is clinically warranted, and a formal diagnosis is scheduled to occur within a reasonable time frame from the date of study entry, then the client may be considered as potentially eligible.
- 0 years through 17 years 11 months of age
- 1\. 0 years to 17 years 11 months of age
Age in the registry: 0 years to 17 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University Of Tennessee Health Science Center Coordinator of this site? Confirm its status | Memphis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.